Schwab unit reports 5.24% stake in Accendra Health

Accendra Health Inc. received a Schedule 13G from Charles Schwab Investment Management Inc. showing a significant institutional position in its common stock.

Rhea-AI Filing Summary

Accendra Health Inc. received a Schedule 13G from Charles Schwab Investment Management Inc. showing a significant institutional position in its common stock. Charles Schwab Investment Management reports beneficial ownership of 4,057,056 shares, representing 5.24% of the outstanding common stock as of the triggering date.

The filing states that Schwab has sole voting and sole dispositive power over all 4,057,056 shares, with no shared voting or dispositive authority. Schwab certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Accendra Health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Accendra Health (ACH) does Charles Schwab Investment Management own?

Charles Schwab Investment Management Inc. reports owning 5.24% of Accendra Health’s common stock. The Schedule 13G shows beneficial ownership of 4,057,056 shares, crossing the 5% reporting threshold that requires public disclosure of significant institutional holdings.

How many Accendra Health (ACH) shares are beneficially owned by Charles Schwab Investment Management?

Charles Schwab Investment Management beneficially owns 4,057,056 Accendra Health common shares. According to the Schedule 13G, this stake represents 5.24% of the company’s outstanding common stock as of the event date requiring the filing.

Does Charles Schwab Investment Management have voting control over its Accendra Health (ACH) shares?

Charles Schwab Investment Management has sole voting power over all 4,057,056 shares. The filing reports sole voting and sole dispositive power, with no shared voting or shared dispositive authority over Accendra Health common stock.

Is Charles Schwab’s Accendra Health (ACH) position intended to influence control of the company?

The filing states the position is not intended to change or influence control. Schwab certifies the securities were acquired and are held in the ordinary course of business, not in connection with any control-related transaction, other than limited nomination-related activities cited in the certification.

What type of filing did Charles Schwab Investment Management submit for Accendra Health (ACH)?

Charles Schwab Investment Management filed a Schedule 13G for Accendra Health. This type of filing discloses beneficial ownership above 5% by investors holding shares in the ordinary course, rather than for the purpose of exerting control over the issuer.

Who signed the Accendra Health (ACH) Schedule 13G for Charles Schwab Investment Management?

The Schedule 13G was signed by Omar Aguilar, Chief Executive Officer. The signature block certifies, after reasonable inquiry, that the information reported about Charles Schwab Investment Management’s 4,057,056-share, 5.24% stake is true, complete, and correct.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:10 PM EST Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ACCENDRA HEALTH INC/VA/

(Name of Issuer)

Common Stock

(Title of Class of Securities)

690732102

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 690732102

1

Names of Reporting Persons

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,057,056.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,057,056.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,057,056.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.24 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ACCENDRA HEALTH INC/VA/
(b)	Address of issuer's principal executive offices: 10900 NUCKOLS ROAD, SUITE 400, GLEN ALLEN, VIRGINIA 23060
Item 2.
(a)	Name of person filing: CHARLES SCHWAB INVESTMENT MANAGEMENT INC
(b)	Address or principal business office or, if none, residence: 9800 Schwab Way Lone Tree, CO 80124
(c)	Citizenship: CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DELAWARE
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 690732102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,057,056
(b)	Percent of class: 5.24 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,057,056
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,057,056
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Signature:	/s/ Omar Aguilar
Name/Title:	Omar Aguilar/Chief Executive Officer
Date:	02/11/2026